A Look at Avity Investment Management Inc.'s Q4 2022 versus Q1 2023 13F Holdings Comparison

Avity Investment Management Inc. is a well-known hedge fund that specializes in large-cap stocks in the technology, healthcare, and financial sectors, among others. As every quarter comes to an end, the Securities and Exchange Commission (SEC) requires all institutional investment managers who manage more than $100 million in qualifying assets to file a Form 13F-HR. This form requires fund managers to disclose their holdings of publicly-traded companies. In this article, we will examine the Q4 2022 versus Q1 2023 13F Holdings Comparison for Avity Investment Management Inc.

Before we get into the details, it is important to understand what a 13F report is and why it matters. The 13F report is an SEC filing required of institutional investment managers who manage over $100 million in qualifying assets. The report discloses the firm's holdings at the end of each quarter and is made publicly available. This information is used by investors, analysts, and the media to gain insight into institutional investment strategies and to identify trends in the market.

Now, let's delve into the details of Avity Investment Management Inc.'s Q4 2022 versus Q1 2023 13F Holdings Comparison. As per the SEC filing, the fund's top five holdings by value as of Q1 2023 were Apple Inc. (AAPL), Pepsico Inc. (PEP), Visa Inc. (V), Amphenol Corp. (APH), and Johnson & Johnson (JNJ). AAPL was the fund's largest holding, accounting for 13.9% of the portfolio, followed by PEP at 7.6%, V at 7.4%, APH at 7.2%, and JNJ at 4.8%. From Q4 2022 to Q1 2023, the fund reduced its holdings in AAPL by 1.5%, PEP by 1.5%, V by 3.2%, and JNJ by 0.07%, while increasing its holdings in APH by 2.5%.

Avity Investment Management Inc. added a new position in Meta Platforms Inc. (META) during the first quarter of 2023. META, formerly known as Facebook, is a social media conglomerate that owns Facebook, Instagram, WhatsApp, and Oculus VR. The SEC filing indicates that the fund acquired 166,205 shares of META, worth approximately $34,060,000 at the end of Q1 2023. The position was new, indicating that the fund had not held any shares of META in the previous quarter. This makes META the fund's sixth-largest holding by value, accounting for 4.4% of the portfolio.

The fund also significantly increased its holdings in Applied Materials Inc. (AMAT) during the first quarter of 2023. AMAT is a leading provider of semiconductor manufacturing equipment to the semiconductor industry. The fund's holdings in AMAT increased from 138,792 shares in Q4 2022 to 224,882 shares in Q1 2023, a 62% increase. The value of the fund's AMAT holdings increased from $13,516,000 in Q4 2022 to $27,622,000 in Q1 2023, a 104.4% increase. This makes AMAT the fund's 11th-largest holding by value, accounting for 0.7% of the portfolio.

Avity Investment Management Inc. reduced its holdings in CVS Health Corp. (CVS) and Bank of America Corp. (BAC) by 20.9% and 7.1%, respectively, during the first quarter of 2023. CVS was the fund's 13th-largest holding, accounting for 0.6% of the portfolio, while BAC was the fund's 32nd-largest holding, accounting for 0.1% of the portfolio. The fund also sold out of its holdings in Marriott Intl Inc. (MAR), United Parcel Service Inc. (UPS), and Dover Corp. (DOV) during the first quarter of 2023.

In conclusion, Avity Investment Management Inc. made several changes to its portfolio during the first quarter of 2023. The fund added a new position in Meta Platforms Inc., significantly increased its holdings in Applied Materials Inc., and reduced its holdings in CVS Health Corp. and Bank of America Corp., among others. This demonstrates the fund's ability to adapt to changing market conditions and its willingness to take advantage of new opportunities. As always, investors and analysts will continue to closely monitor the fund's 13F filings in the coming quarters to gain insights into its investment strategy and decision-making process.